검색 상세

Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status

  • 주제(키워드) Comorbidity , Diabetes mellitus , Hypercholesterolemia , Hypertension , Prediabetic state , Prevalence
  • 주제(기타) Endocrinology & Metabolism
  • 설명문(일반) [Jung, Chan-Hee; Mok, Ji-Oh] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, 170 Jomaru Ro, Bucheon 14584, South Korea; [Son, Jang Won; Lee, Seong-Su; Kim, Sung Rae] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Bucheon, South Korea; [Kang, Shinae] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Won Jun] Univ Ulsan, Gangneung Asan Hosp, Dept Endocrinol & Metab, Coll Med, Kangnung, South Korea; [Kim, Hun-Sung] Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea; [Kim, Hae Soon] Ewha Womans Univ, Dept Pediat, Sch Med, Seoul, South Korea; [Seo, Mihae] Soonchunhyang Univ, Gumi Hosp, Dept Endocrinol & Metab, Coll Med, Gumi, South Korea; [Shin, Hye-Jung] Natl Med Ctr, Dept Pediat, Seoul, South Korea; [Jeong, Su Jin] Sejong Gen Hosp, Dept Endocrinol & Metab, Bucheon, South Korea; [Cho, Yongin] Inha Univ, Dept Endocrinol & Metab, Sch Med, Incheon, South Korea; [Han, Seung Jin] Ajou Univ, Dept Endocrinol & Metab, Sch Med, Suwon, South Korea; [Jang, Hyang Mi] Yonsei Univ, Gangnam Severance Hosp, Dept Nursing, Seoul, South Korea; [Rho, Mira] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Nutr, Seoul, South Korea; [Lee, Shinbi] Korea Univ, Dept Clin Nutr, Anam Hosp, Seoul, South Korea; [Koo, Mihyun] Samsung Med Ctr, Dept Social Work, Seoul, South Korea; [Yoo, Been] Kyung Hee Univ Hosp Gangdong, Dept Social Work, Seoul, South Korea; [Moon, Jung-Wha] Inje Univ, Dept Sports Med Ctr, Ilsan Paik Hosp, Goyang, South Korea; [Lee, Hye Young] Asan Med Ctr, Sport Hlth Med Ctr, Seoul, South Korea; [Yun, Jae-Seung] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Suwon, South Korea; [Kim, Sun Young] Samsung Med Ctr, Dept Nursing, Seoul, South Korea; [Jeong, In-Kyung] Kyung Hee Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Seoul, South Korea; [Yoon, Kun Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
  • 등재 SCIE, SCOPUS, KCI등재
  • 발행기관 KOREAN DIABETES ASSOC
  • 발행년도 2021
  • 총서유형 Journal
  • URI http://www.dcollection.net/handler/ewha/000000181485
  • 본문언어 영어
  • Published As http://dx.doi.org/10.4093/dmj.2020.0254

초록/요약

Background: This study aimed to investigate the recent prevalence, management, and comorbidities of diabetes among Korean adults aged >= 30 years by analyzing nationally representative data. Methods: This study used data from the Korea National Health and Nutrition Examination Survey from 2016 to 2018, and the percentage and total number of people >= 30 years of age with diabetes and impaired fasting glucose (IFG) were estimated. Results: In 2018, 13.8% of Korean adults aged >= 30 years had diabetes, and adults aged >= 65 years showed a prevalence rate of 28%. The prevalence of IFG was 26.9% in adults aged >= 30 years. From 2016 to 2018, 35% of the subjects with diabetes were not aware of their condition. Regarding comorbidities, 53.2% and 61.3% were obese and hypertensive, respectively, and 72% had hypercholesterolemia as defined by low-density lipoprotein cholesterol (LDL-C) >= 100 mg/dL in people with diabetes. Of the subjects with diabetes, 43.7% had both hypertension and hypercholesterolemia. With regard to glycemic control, only 28.3% reached the target level of <6.5%. Moreover, only 11.5% of subjects with diabetes met all three targets of glycosylated hemoglobin, blood pressure, and LDL-C. The percentage of energy intake from carbohydrates was higher in diabetes patients than in those without diabetes, while that from protein and fat was lower in subjects with diabetes. Conclusion: The high prevalence and low control rate of diabetes and its comorbidities in Korean adults were confirmed. More stringent efforts are needed to improve the comprehensive management of diabetes to reduce diabetes-related morbidity and mortality.

more